Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Marques

Showing results (571-580 of 589) with videos related to

Pageof 59
Sort By:
JAMA|April 5, 2012
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer riskWendie A Berg, Zheng Zhang, Daniel Lehrer, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 24, 2018
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trialDavid C Newitt, Zheng Zhang, Jessica E Gibbs, et al.
Nature Communications|February 24, 2018
An ancient family of lytic polysaccharide monooxygenases with roles in arthropod development and biomass digestionFederico Sabbadin, Glyn R Hemsworth, Luisa Ciano, et al.
Molecules (Basel, Switzerland)|May 27, 2026
Structure-Activity Relationship Analysis of Flavonoids Isolated from the Leaves of <i>Erythroxylum rimosum</i> O. E. SchulzIvana P Dos Santos, Maria Eduarda V Costa, Geovana A de Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2025
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancerA Mamann, Y Pradat, F C Bidard, et al.
Human Immunology|July 5, 2025
Elevated regulatory T cells in pediatric patients recovering from multisystem inflammatory syndrome (MIS-C) are evident five months post-COVID-19Isabela Silva-Avelar, Bruna Danielly Santos-Silva, Yingying Zheng, et al.
Lancet Regional Health. Americas|March 21, 2022
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma <i>versus</i> standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)Alice T W Song, Vanderson Rocha, Alfredo Mendrone-Júnior, et al.
Computational and Structural Biotechnology Journal|April 2, 2014
Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experienceFernanda A Dorella, Alfonso Gala-Garcia, Anne C Pinto, et al.
ESMO Open|July 6, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study)G Roviello, F Ciccimarra, F Urabe, et al.
Cytokine|November 20, 2022
Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C)Guilherme S Gonçalves, Simone Correa-Silva, Yingying Zheng, et al.
Pageof 59

Showing results (571-580 of 589) with videos related to

Sort By:
Pageof 59
JAMA|April 5, 2012
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer riskWendie A Berg, Zheng Zhang, Daniel Lehrer, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 24, 2018
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trialDavid C Newitt, Zheng Zhang, Jessica E Gibbs, et al.
Nature Communications|February 24, 2018
An ancient family of lytic polysaccharide monooxygenases with roles in arthropod development and biomass digestionFederico Sabbadin, Glyn R Hemsworth, Luisa Ciano, et al.
Molecules (Basel, Switzerland)|May 27, 2026
Structure-Activity Relationship Analysis of Flavonoids Isolated from the Leaves of <i>Erythroxylum rimosum</i> O. E. SchulzIvana P Dos Santos, Maria Eduarda V Costa, Geovana A de Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2025
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancerA Mamann, Y Pradat, F C Bidard, et al.
Human Immunology|July 5, 2025
Elevated regulatory T cells in pediatric patients recovering from multisystem inflammatory syndrome (MIS-C) are evident five months post-COVID-19Isabela Silva-Avelar, Bruna Danielly Santos-Silva, Yingying Zheng, et al.
Lancet Regional Health. Americas|March 21, 2022
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma <i>versus</i> standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)Alice T W Song, Vanderson Rocha, Alfredo Mendrone-Júnior, et al.
Computational and Structural Biotechnology Journal|April 2, 2014
Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experienceFernanda A Dorella, Alfonso Gala-Garcia, Anne C Pinto, et al.
ESMO Open|July 6, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study)G Roviello, F Ciccimarra, F Urabe, et al.
Cytokine|November 20, 2022
Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C)Guilherme S Gonçalves, Simone Correa-Silva, Yingying Zheng, et al.
Pageof 59